Literature DB >> 2033081

On the multimeric nature of natural human interleukin-6.

L T May1, U Santhanam, P B Sehgal.   

Abstract

Natural human interleukin-6 (IL-6) characterized under completely denaturing conditions consists of a set of differentially modified phosphoglycoproteins of molecular mass in the range from 23 to 30 kDa ("25-kDa" O-glycosylated species and "30-kDa" O- and N-glycosylated species). The 25-kDa O-glycosylated IL-6 (which contains only Ser- or Thr-GalNAc-Gal-NeuNAc and thus should not bind wheat germ or lentil lectins) bound to and was eluted from a wheat germ lectin affinity column by GlcNAc and from a lentil lectin affinity column by methyl-alpha-D-Man suggesting that the 25-kDa IL-6 species formed heteromeric complexes with the N-glycosylated 30-kDa IL-6. In non-denaturing gels (0.2% Nonidet P-40-polyacrylamide gel electrophoresis (PAGE)), even under reducing conditions (15 mM dithiothreitol or 1 M beta-mercaptoethanol and heating), fibroblast-derived IL-6 migrated as a predominant complex of mass approximately 85 kDa and additional minor 45-65-kDa complexes. Little IL-6 was detected in the size range 23-30 kDa. Elution of the major 85-kDa complex and re-electrophoresis through sodium dodecyl sulfate-PAGE revealed that it represented a heteromeric aggregate of the 25- and 30-kDa IL-6 species; the 45-65-kDa complexes were largely composed of the 25-kDa protein. The bulk of fibroblast-derived IL-6 eluted in the size range 45-85 kDa from a Sephadex G-200 gel filtration column further indicating that fibroblast-derived IL-6 was largely multimeric even in dilute solutions. Functionally, the high molecular mass IL-6 fractions from the G-200 column were less active in the B9 hybridoma growth factor assay than the lower molecular mass fractions but appeared to be equally active in the Hep3B hepatocyte-stimulating factor assay. Taken together, the data indicate that natural human IL-6 exists as a multimeric aggregate with varying biological activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033081

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels.

Authors:  A Corti; G Fassina; F Marcucci; E Barbanti; G Cassani
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

2.  Sex difference in link between interleukin-6 and stress.

Authors:  Ryan Jankord; James R Turk; James C Schadt; Jennifer Casati; Venkataseshu K Ganjam; Elmer M Price; Duane H Keisler; M Harold Laughlin
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

3.  Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling.

Authors:  Guglielmina Chimienti; Anna Mezzapesa; Grazia M Liuzzi; Tiziana Latronico; Gabriella Pepe
Journal:  Inflamm Res       Date:  2010-11-02       Impact factor: 4.575

4.  Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.

Authors:  Shalini Chaturvedi; Derick Siegel; Carrie L Wagner; Jaehong Park; Helgi van de Velde; Jessica Vermeulen; Man-Cheong Fung; Manjula Reddy; Brett Hall; Kate Sasser
Journal:  Br J Clin Pharmacol       Date:  2015-06-04       Impact factor: 4.335

Review 5.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

6.  Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.

Authors:  M R Graf; R E Merchant
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 7.  Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate.

Authors:  A S Goldman; S Chheda; R Garofalo; F C Schmalstieg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

8.  Complete 1H, 15N and 13C assignments, secondary structure, and topology of recombinant human interleukin-6.

Authors:  G Y Xu; J Hong; T McDonagh; M Stahl; L E Kay; J Seehra; D A Cumming
Journal:  J Biomol NMR       Date:  1996-09       Impact factor: 2.835

Review 9.  Extraction of proteins from gels: a brief review.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  Methods Mol Biol       Date:  2012

10.  Recombinant production of human interleukin 6 in Escherichia coli.

Authors:  Henrik Nausch; Jana Huckauf; Roswitha Koslowski; Udo Meyer; Inge Broer; Heike Mikschofsky
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.